Pitfalls of the application of microdialysis in clinical oncology: Controversial findings with docetaxel

Journal of Pharmaceutical and Biomedical Analysis

Volumn 45, Issue 2, 2007, Pages 288-294

  Loos, W J ^a   Zamboni, W C ^b,c,d   Engels, F K ^a   de Bruijn, P ^a   Lam, M H ^a   de Wit, R ^a   Verweij, J ^a   Wiemer, E A C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Docetaxel; Microdialysis; Non specific binding; Polyurethane

Indexed keywords

DOCETAXEL; PACLITAXEL; POLYSORBATE 80;

ARTICLE; CATHETER; DRUG BINDING; HUMAN; MICRODIALYSIS; ONCOLOGY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, LIQUID; CLINICAL PROTOCOLS; HUMANS; MASS SPECTROMETRY; MICRODIALYSIS; TAXOIDS;

EID: 34848923745     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.07.023     Document Type: Article

References (30)

1. Balch C.M., Reintgen D.S., Kirkwood J.M., et al. In: DeVita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer: Principles and Practice of Oncology. 5th ed. (1947), Lippincott-Raven, Philadelphia
2. Jain R.K. Science 271 (1996) 1079-1080
3. Zamboni W.C., Houghton P.J., Hulstein J.L., Kirstein M., Walsh J., Cheshire P.J., Hanna S.K., Danks M.K., and Stewart C.F. Cancer Chemother. Pharmacol. 43 (1999) 269-276
4. Muller M., Mader R.M., Steiner B., Steger G.G., Jansen B., Gnant M., Helbich T., Jakesz R., Eichler H.G., and Blochl-Daum B. Cancer Res. 57 (1997) 2598-2601
5. Blochl-Daum B., Muller M., Meisinger V., Eichler H.G., Fassolt A., and Pehamberger H. Br. J. Cancer 73 (1996) 920-924
6. Elmquist W.F., and Sawchuk R.J. Pharm. Res. 14 (1997) 267-288
7. Hansen D.K., Davies M.I., Lunte S.M., and Lunte C.E. J. Pharm. Sci. 88 (1999) 14-27
8. de la Pena A., Liu P., and Derendorf H. Adv. Drug Deliv. Rev. 45 (2000) 189-216
9. de Lange E.C., de Boer A.G., and Breimer D.D. Adv. Drug Deliv. Rev. 45 (2000) 125-148
10. Brunner M., Muller M., and Eur. J. Clin. Pharmacol. 58 (2002) 227-234
11. Verbeeck R.K. Adv. Drug Deliv. Rev. 45 (2000) 217-228
12. Tsai T.H. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 797 (2003) 161-173
13. Kitzen J.J., Verweij J., Wiemer A.C., and Loos W.J. Curr. Clin. Pharmacol. 1 (2006) 255-263
14. Bruno R., Hille D., Riva A., Vivier N., ten Bokkel Huinnink W.W., van Oosterom A.T., Kaye S.B., Verweij J., Fossella F.V., Valero V., Rigas J.R., Seidman A.D., Chevallier B., Fumoleau P., Burris H.A., Ravdin P.M., and Sheiner L.B. J. Clin. Oncol. 16 (1998) 187-196
15. In: Zamboni W.C., Figg W.D., and McLeod H. (Eds). Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (2004), Human Press, New Jersy 307-326
16. Schuck V.J., Rinas I., and Derendorf H. J. Pharm. Biomed. Anal. 36 (2004) 807-813
17. Bungay P.M., Dedrick R.L., Fox E., and Balis F.M. Pharm. Res. 18 (2001) 361-366
18. Cano-Cebrian M.J., Zornoza T., Polache A., and Granero L. Curr. Drug Metab. 6 (2005) 83-90
19. W.C. Zamboni, S. Strychor, J.E., R. Parise, M.J. Egorin, J.L. Eiseman, 2007, submitted for publication.
20. Bissery M.C., Nohynek G., Sanderink G.J., and Lavelle F. Anticancer Drugs 6 (1995) 339-355, 338-363
21. Sparreboom A., van Tellingen O., Nooijen W.J., and Beijnen J.H. Anticancer Drugs 9 (1998) 1-17
22. Zamboni W.C. Clin. Cancer Res. 11 (2005) 8230-8234
23. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C., et al. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 11460-11464
24. Ibrahim N.K., Desai N., Legha S., Soon-Shiong P., Theriault R.L., Rivera E., Esmaeli B., Ring S.E., Bedikian A., Hortobagyi G.N., and Ellerhorst J.A. Clin. Cancer Res. 8 (2002) 1038-1044
25. Pitt W.G., Grasel T.G., and Cooper S.L. Biomaterials 9 (1988) 36-46
26. Traunmuller F., Steiner I., Zeitlinger M., and Joukhadar C. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 843 (2006) 142-146
27. Loos W.J., Baker S.D., Verweij J., Boonstra J.G., and Sparreboom A. Clin. Pharmacol. Ther. 74 (2003) 364-371
28. Lindberger M., Tomson T., and Lars S. Pharmacol. Toxicol. 91 (2002) 158-165
29. Carneheim C., and Stahle L. Pharmacol. Toxicol. 69 (1991) 378-380
30. Khramov A.N., and Stenken J.A. Analyst 124 (1999) 1027-1033